HRTX Q1 2019 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$153M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$32M+173.2% YoY

Gross Profit

$17M52.7% margin

Operating Income

-$65M-204.7% margin

Net Income

-$63M-199.4% margin

EPS (Diluted)

$-0.80

QoQ Revenue Growth

+9.6%

Cash Flow

Operating Cash Flow

-$49M

Free Cash Flow

-$51M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$436M

Total Liabilities

$104M

Stockholders' Equity

$332M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$32M	$12M	+173.2%
Gross Profit	$17M	$8M	+97.3%
Operating Income	-$65M	-$52M	-24.4%
Net Income	-$63M	-$52M	-20.6%